Get the Stockscreener App
13.04
1.58%
-0.21
After Hours:
13.03
-0.010
-0.08%
Uipath Inc stock is traded at $13.04, with a volume of 54.31M.
It is down -1.58% in the last 24 hours and down -20.44% over the past month.
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.
See More
Previous Close:
$13.25
Open:
$13.235
24h Volume:
54.31M
Relative Volume:
0.78
Market Cap:
$6.80B
Revenue:
$1.61B
Net Income/Loss:
$282.33M
P/E Ratio:
24.97
EPS:
0.5223
Net Cash Flow:
$352.16M
1W Performance:
-4.33%
1M Performance:
-20.44%
6M Performance:
+7.50%
1Y Performance:
+4.07%
1-Day Range:
$12.65
$13.37
1-Week Range:
$12.65
$14.04
52-Week Range:
$9.2002
$19.84
Uipath Inc Stock (PATH) Company Profile
Name
Uipath Inc
Sector
Industry
Phone
(844) 432-0455
Address
ONE VANDERBILT AVENUE, NEW YORK
Compare PATH vs MSFT, PLTR, ORCL, CRWD, FTNT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PATH
Uipath Inc
|
13.04 | 6.91B | 1.61B | 282.33M | 352.16M | 0.5223 |
MSFT
Microsoft Corp
|
500.59 | 3.70T | 318.27B | 125.22B | 72.92B | 16.79 |
PLTR
Palantir Technologies Inc
|
191.79 | 444.54B | 5.22B | 2.29B | 2.69B | 0.8876 |
ORCL
Oracle Corp
|
144.56 | 451.14B | 67.36B | 17.31B | -23.69B | 5.8248 |
CRWD
Crowdstrike Holdings Inc
|
262.49 | 256.05B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
178.74 | 127.86B | 7.11B | 1.95B | 2.44B | 2.5883 |
Uipath Inc Stock (PATH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Needham | Hold → Buy |
| Oct-02-25 | Reiterated | BMO Capital Markets | Market Perform |
| Sep-05-25 | Reiterated | BMO Capital Markets | Market Perform |
| Sep-05-25 | Resumed | DA Davidson | Neutral |
| Mar-13-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-12-24 | Initiated | UBS | Sell |
| Jun-03-24 | Downgrade | Macquarie | Outperform → Neutral |
| May-30-24 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-30-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-24 | Downgrade | Truist | Buy → Hold |
| May-30-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-08-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Mar-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-14-24 | Reiterated | Needham | Buy |
| Feb-21-24 | Initiated | Scotiabank | Sector Perform |
| Jan-02-24 | Initiated | William Blair | Outperform |
| Jun-09-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-21-23 | Initiated | DA Davidson | Neutral |
| Mar-16-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-03-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-18-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Sep-07-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-22 | Downgrade | Mizuho | Buy → Neutral |
| Sep-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Resumed | Canaccord Genuity | Buy |
| Jan-25-22 | Upgrade | Macquarie | Neutral → Outperform |
| Jan-20-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-09-21 | Upgrade | Berenberg | Hold → Buy |
| Dec-03-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-16-21 | Initiated | Credit Suisse | Outperform |
| Sep-17-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Jul-12-21 | Initiated | Summit Insights | Sell |
| May-17-21 | Initiated | BMO Capital Markets | Market Perform |
| May-17-21 | Initiated | Barclays | Equal Weight |
| May-17-21 | Initiated | BofA Securities | Buy |
| May-17-21 | Initiated | Canaccord Genuity | Hold |
| May-17-21 | Initiated | Cowen | Outperform |
| May-17-21 | Initiated | DA Davidson | Buy |
| May-17-21 | Initiated | Evercore ISI | In-line |
| May-17-21 | Initiated | JP Morgan | Neutral |
| May-17-21 | Initiated | KeyBanc Capital Markets | Overweight |
| May-17-21 | Initiated | Macquarie | Neutral |
| May-17-21 | Initiated | Mizuho | Buy |
| May-17-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-17-21 | Initiated | Needham | Buy |
| May-17-21 | Initiated | Oppenheimer | Perform |
| May-17-21 | Initiated | RBC Capital Mkts | Sector Perform |
| May-17-21 | Initiated | Truist | Buy |
| May-17-21 | Initiated | Wells Fargo | Equal Weight |
| May-17-21 | Initiated | Wolfe Research | Peer Perform |
| May-13-21 | Initiated | Berenberg | Hold |
View All
Uipath Inc Stock (PATH) Latest News
Truist Trims UiPath Target After Investor Day Skips New Goals - GuruFocus
'LLMs don't learn': Dines launches UiPath Cartographer - The Next Web
Genzeon Named UiPath 2026 Industry Impact Partner of the Year for Healthcare and Life Sciences - PR Newswire
UiPath Stock Falls as Analyst Highlights Expanding AI Opportunity - Benzinga
Truist Securities maintains Hold rating on UiPath, $14 price target - TradingView
UiPath, Inc. Announces New And Planned Enhancements To UiPath Test Cloud - marketscreener.com
UiPath's Transition to Business Orchestration, Automation Technologies Remains 'Show-Me Story,' RBC Says - marketscreener.com
TD Cowen Reaffirms Hold Rating for UiPath (NYSE:PATH) - MarketBeat
UiPath Inc (Derivatives) to Canadian Dollar Price Today | Live PATH to CAD Converter & Exchange Rate - CryptoRank
Truist cuts UiPath stock price target to $14 on sector volatility - Investing.com Canada
UiPath stock price target cut to $15 by UBS on FY28 outlook - Investing.com Canada
RBC Capital cuts UiPath stock price target on execution concerns By Investing.com - Investing.com Canada
UBS Adjusts UiPath Price Target to $15 From $19, Maintains Neutral Rating - marketscreener.com
RBC Capital cuts UiPath stock price target on execution concerns - Investing.com
UiPath Expands Test Cloud With Autonomous Testing Features - marketscreener.com
UBS Group Has Lowered Expectations for UiPath (NYSE:PATH) Stock Price - MarketBeat
UiPath announces new AI upgrades: Will PATH stock rebound now? - TradingView
RBC Cuts Price Target on UiPath to $15 From $17, Keeps Sector Perform Rating - marketscreener.com
RBC Capital maintains Sector Perform rating on UiPath, $15 price target - TradingView
Ashling Recognized as a UiPath 2026 Partner of the Year Award Winner - Yahoo Finance
Truist Cuts Price Target on UiPath to $14 From $17, Keeps Hold Rating - marketscreener.com
Needham reiterates UiPath stock buy rating on AI automation focus By Investing.com - Investing.com Canada
UiPath announces platform updates for enterprise automation By Investing.com - Investing.com Canada
UiPath announces AI-powered testing enhancements for Test Cloud By Investing.com - Investing.com Canada
UiPath Honors 2026 Partner Award Winners at its FUSION Conference - Yahoo Finance
UiPath launches Cartographer for enterprise process mapping By Investing.com - Investing.com Canada
Companies can keep UiPath's full automation platform on their own systems. - Stock Titan
UiPath Test Cloud Accelerates Autonomous Testing at Enterprise Scale - Yahoo Finance Singapore
UiPath Launches UiPath Cartographer, Helping Enterprises Turn Scattered Process Knowledge into an Actionable View of How Their Business Runs - Yahoo Finance Singapore
Needham reiterates UiPath stock buy rating on AI automation focus - Investing.com
UiPath (NYSE:PATH) Earns Buy Rating from Needham & Company LLC - MarketBeat
Needham reiterates Buy rating on UiPath, $22 price target - TradingView
Connecting the Dots on UiPath’s Investor Day: The Evolution of the Enterprise Control Plane - Moomoo
UiPath Targets $2B ARR With AI Orchestration Push at Investor Day - MarketBeat
UiPath (PATH) Could Be 39% Undervalued After PLDT Showed AI Automation Gains - simplywall.st
UiPath Inc : RBC Cuts Target Price to $15 Fro - Moomoo
(PATH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
UiPath Execs, Investor Clash Over Bid To Ax Derivative Suit - Law360
Is UiPath Stock Cheap Because Of What AI Might Do? - Yahoo Finance
UiPath, Inc. (PATH) stock price, news, quote and history - Yahoo Finance UK
UiPath's CTO Sells Over 40,000 Shares Amid a 16% One-Year Return - The Motley Fool
Why Is UiPath (NYSE:PATH) Gaining Focus in Technology Stocks? - kalkinemedia.com
UiPath's CTO Sells Over 40,000 Shares Amid a 16% One-Year Return - The Motley Fool
UiPath CPO & CTO Malpani sells $566k in stock By Investing.com - Investing.com South Africa
UiPath CPO & CTO Malpani sells $566k in stock - Investing.com
Raghavendra Malpani Sells 40,464 Shares of UiPath (NYSE:PATH) Stock - MarketBeat
UiPath (PATH) CPO & CTO sells 40K shares in planned trade - Stock Titan
UiPath Inc (Derivatives) to Russian Ruble Price Today | Live PATH to RUB Converter & Exchange Rate - CryptoRank
UiPath Inc (Derivatives) to Vietnamese Dong Price Today | Live PATH to VND Converter & Exchange Rate - CryptoRank
UiPath Inc (Derivatives) to Euro Price Today | Live PATH to EUR Converter & Exchange Rate - CryptoRank
UiPath Inc (Derivatives) Analytics: Price Dynamics, Quarterly Returns, and Annual Price Changes in USD - CryptoRank
Uipath Inc Stock (PATH) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.68%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):